You are here

Enanta

Enanta's NASH drug barely meets main goal in mid-stage study

Endpoints

Thu, 09/26/19 - 10:59 am

clinical trials

AbbVie, Enanta post stellar hep C PhIII data, but no one is cheering

Endpoints

Thu, 04/20/17 - 08:52 pm

glecaprevir/pibrentasvir

Enanta, among Boston's few profitable biotechs, earns another $30M

Bizjournals.com

Mon, 09/28/15 - 08:41 am

Cubist, Enanta and Vertex still await FDA approval decisions this year

Bizjournals.com

Fri, 12/19/14 - 04:11 pm

Vertex Pharmaceuticals

Can Partnering To Fight Hepatitis C Pay At Enanta?

Investors.com

Mon, 11/24/14 - 06:23 pm

Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.

Motley Fool

Fri, 11/7/14 - 10:11 am

Gilead Sciences

[video]Biotech Losers: InterMune, Enanta, and GW Pharmaceuticals

Motley Fool

Fri, 02/7/14 - 10:49 am

Enanta Joins Big Leagues With Hepatitis C Drug

Investors.com

Wed, 01/8/14 - 08:07 am

protease inhibitors

Why Enanta Pharmaceuticals Shares Sank Like a Stone

Motley Fool

Thu, 12/19/13 - 08:08 am

Gilead Sciences

A Chart You Should See: Biotech IPO Class of 2013 Is Lagging

TheStreet.com

Tue, 11/26/13 - 10:33 am

Portola Pharmaceuticals

2 Biotech Stocks Rising on Big Volume

TheStreet.com

Tue, 11/26/13 - 09:02 am

Upcoming Catalysts Should Provide Strong Upside For These BioPharma Companies

Seeking Alpha

Fri, 10/18/13 - 10:51 am

ImmunoCellular Therapeutics

Merrimack Pharmaceuticals

3 Humongous Health-Care Stocks This Week

Motley Fool

Sun, 09/22/13 - 11:08 am

3 Biotechs With Recent Intensive Insider Buying

Seeking Alpha

Sun, 04/7/13 - 10:52 am

Tetraphase Pharmaceuticals

Hepatitis C Remains A Hot Play

Seeking Alpha

Mon, 02/27/12 - 12:01 pm

Bristol-Myers Squibb

Enanta partners with Novartis to develop new drug to treat hepatitis C virus

Boston Globe, MA

Tue, 02/21/12 - 09:36 am

Abbott and Enanta begin hepatitis C trials

Hays Pharma, UK

Thu, 02/19/09 - 08:38 am

Abbott Laboratories